pcDNA3-ALK2 wt Citations (4)

Originally described in: The protein kinase LKB1 negatively regulates bone morphogenetic protein receptor signaling.
Raja E, Tzavlaki K, Vuilleumier R, Edlund K, Kahata K, Zieba A, Moren A, Watanabe Y, Voytyuk I, Botling J, Soderberg O, Micke P, Pyrowolakis G, Heldin CH, Moustakas A Oncotarget. 2016 Jan 12;7(2):1120-43. doi: 10.18632/oncotarget.6683. PubMed Journal

---

Articles Citing pcDNA3-ALK2 wt

Articles
Polymodal allosteric regulation of Type 1 Serine/Threonine Kinase Receptors via a conserved electrostatic lock. Botello-Smith WM, Alsamarah A, Chatterjee P, Xie C, Lacroix JJ, Hao J, Luo Y. PLoS Comput Biol. 2017 Aug 21;13(8):e1005711. doi: 10.1371/journal.pcbi.1005711. eCollection 2017 Aug. PubMed
Insight into Molecular Mechanism for Activin A-Induced Bone Morphogenetic Protein Signaling. Xie C, Jiang W, Lacroix JJ, Luo Y, Hao J. Int J Mol Sci. 2020 Sep 5;21(18). pii: ijms21186498. doi: 10.3390/ijms21186498. PubMed
A defined clathrin-mediated trafficking pathway regulates sFLT1/VEGFR1 secretion from endothelial cells. Kinghorn K, Gill A, Marvin A, Li R, Quigley K, le Noble F, Mac Gabhann F, Bautch VL. bioRxiv. 2023 Jan 28:2023.01.27.525517. doi: 10.1101/2023.01.27.525517. Preprint. PubMed
High concentrations of soluble endoglin can inhibit BMP9 signaling in non-endothelial cells. Andersson-Rusch C, Liu B, Quist-Lokken I, Upton PD, Olsen OE, Hella H, Yang X, Tong Z, Morrell NW, Holien T, Li W. Sci Rep. 2023 Apr 24;13(1):6639. doi: 10.1038/s41598-023-33352-3. PubMed

If you have published an article using this material, please email us at to have your article added to this page.